Table 2. 30-Day and 1-Year Adjudicated Outcomesa.
| Outcome | No. (%) | P Value | |
|---|---|---|---|
| TAVR (n = 136) | SAVR (n = 137) | ||
| 30-d Outcomes | |||
| All-cause mortality or disabling stroke | 1 (0.7) | 4 (2.9) | .18 |
| All-cause mortality | 0 | 1 (0.7) | .32 |
| Cardiovascular mortality | 0 | 1 (0.7) | .32 |
| All stroke | 5 (3.7) | 7 (5.1) | .55 |
| Disabling stroke | 1 (0.7) | 3 (2.2) | .31 |
| Life-threatening or disabling bleeding | 7 (5.1) | 8 (5.9) | .80 |
| Major bleeding | 10 (7.4) | 11 (8.1) | .83 |
| Transfusion of PRBCs, unitsb | 13 (9.6) | 53 (38.7) | <.001 |
| 2-3 | 6 (4.4) | 26 (19.0) | <.001 |
| ≥4 | 4 (2.9) | 17 (12.4) | <.001 |
| Major vascular complications | 7 (5.1) | 3 (2.2) | .20 |
| Acute kidney injury stage 2 or 3 | 0 | 4 (2.9) | .04 |
| Myocardial infarction | 1 (0.7) | 1 (0.7) | >.99 |
| Permanent pacemaker | 33 (24.3) | 7 (5.2) | <.001 |
| Atrial fibrillation | 13 (9.6) | 55 (37.5) | <.001 |
| 1-y Outcomes | |||
| All-cause mortality or disabling stroke | 12 (8.9) | 10 (6.7) | .53 |
| All-cause mortality | 8 (5.9) | 6 (4.5) | .60 |
| Cardiovascular mortality | 6 (4.5) | 6 (4.5) | .99 |
| All stroke | 9 (6.7) | 10 (7.5) | .79 |
| Disabling stroke | 4 (3.0) | 4 (3.0) | .99 |
| Life-threatening or disabling bleeding | 9 (6.7) | 11 (8.2) | .65 |
| Major bleeding | 14 (10.4) | 17 (12.0) | .70 |
| Myocardial infarction | 2 (1.5) | 4 (3.0) | .40 |
| Permanent pacemaker | 41 (29.0) | 12 (9.0) | <.001 |
| Atrial fibrillation | 22 (13.3) | 63 (39.0) | <.001 |
| Aortic valve hospitalization | 18 (6.7) | 8 (6.0) | .82 |
| Reintervention | 4 (2.2) | 1 (0.7) | .32 |
Abbreviations: PRBC, packed red blood cell; SAVR, surgical aortic valve replacement; TAVR, transcatheter aortic valve replacement.
a
Data are presented as events (Kaplan-Meier estimates), and P values are calculated based on the log-rank test.
b
Transfusion of PRBCs is presented as events (percentage rate).